نود ابلاغكم انه تم نشر اعلان خاطئ عن علاج السكري يذكر به ان هذا العلاج هو علاج نهائي للمرض والذي يكلف 3700 ريال سعودي. للحصول على المعلومات الصحيحة نرجوا منكم التواصل معنا.
العربية
+38 093 055 22 40
00380689869898 (汉语)
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
طلب البيانات

Our licences

Fetal stem cells are effective in the treatment of Grade Ⅰ and Ⅱ respiratory failure in amyotrophic lateral sclerosis and muscular dystrophy

As our study shows, fetal stem cell treatment improved both subjective and objective breathing parameters as early as 6 months post‐treatment in patients wirh respiratory failure. A significant increase in the forced vital capacity and forced expiratory volume in 1 second was reported by all patients with grade Ⅰ respiratory failure linked to ALS and MD compared to baseline. Patient respiratory improvement was maintained over the next 6 months. Grade Ⅱ RF patients with MD reported a significant improvement in FVC 12 months after treatment.

Read more:
Nataliia S. Sych, Olena V. Ivankova , Mariya O. Klunnyk, Iryna G. Matiyashchuk, Andrey A. Sinelnyk, Mariya P. Demchyk, Maryna V. Skalozyb, Dario Siniscalco. Fetal stem cells are effective in the treatment of Grade Ⅰ and Ⅱ respiratory failure in amyotrophic lateral sclerosis and muscular dystrophy. // Translational Neuroscience and Clinics. – September 2015. – No. 1 Vol. 1, pp. 10–16.


Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.